Stay updated on Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A MedlinePlus Genetics-related listing for type 2 diabetes was removed, and the site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.2%
    Check dated 2026-11-21T15:22:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 2 study of tesofensine/metoprolol for adults with type 2 diabetes, including its eligibility criteria, treatment arms, outcomes, and posted study documents.
    Difference
    44%
    Check dated 2026-11-07T14:50:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than a study record.
    Difference
    0.2%
    Check dated 2026-10-31T15:42:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related terminology update, including the use of “Super Intelligence” in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T18:39:01.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T18:47:58.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T19:23:25.000Z thumbnail image

Stay in the know with updates to Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.